Toronto Dominion Bank Acquires 9,209 Shares of Axon Enterprise, Inc. (NASDAQ:AXON)

Toronto Dominion Bank raised its stake in shares of Axon Enterprise, Inc. (NASDAQ:AXON - Free Report) by 38.3% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 33,273 shares of the biotechnology company's stock after acquiring an additional 9,209 shares during the period. Toronto Dominion Bank's holdings in Axon Enterprise were worth $19,775,000 as of its most recent SEC filing.

Several other large investors have also bought and sold shares of AXON. Cache Advisors LLC bought a new stake in shares of Axon Enterprise during the 4th quarter worth $2,379,000. GF Fund Management CO. LTD. bought a new stake in shares of Axon Enterprise during the 4th quarter worth $4,656,000. Fourth Dimension Wealth LLC bought a new stake in shares of Axon Enterprise during the 4th quarter worth $30,000. Pinkerton Retirement Specialists LLC bought a new stake in shares of Axon Enterprise during the 4th quarter worth $1,002,000. Finally, Castleark Management LLC raised its stake in shares of Axon Enterprise by 317.7% during the 4th quarter. Castleark Management LLC now owns 11,570 shares of the biotechnology company's stock worth $6,876,000 after purchasing an additional 8,800 shares during the period. 79.08% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

A number of equities research analysts have recently commented on the company. JMP Securities reiterated an "outperform" rating on shares of Axon Enterprise in a research note on Tuesday, February 4th. The Goldman Sachs Group lifted their target price on Axon Enterprise from $730.00 to $830.00 and gave the stock a "buy" rating in a research note on Wednesday, May 14th. Northcoast Research cut Axon Enterprise from a "buy" rating to a "neutral" rating in a research note on Wednesday, February 19th. Needham & Company LLC lifted their price objective on Axon Enterprise from $600.00 to $750.00 and gave the stock a "buy" rating in a report on Thursday, May 8th. Finally, Craig Hallum lowered Axon Enterprise from a "buy" rating to a "cautious" rating in a report on Monday, March 10th. One research analyst has rated the stock with a sell rating, one has assigned a hold rating and ten have given a buy rating to the company. According to data from MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and a consensus price target of $652.73.

Axon Enterprise Price Performance

AXON stock traded up $13.34 during mid-day trading on Friday, reaching $743.63. 1,121,061 shares of the company traded hands, compared to its average volume of 732,673. The company has a debt-to-equity ratio of 0.32, a current ratio of 2.96 and a quick ratio of 2.63. The company has a market capitalization of $57.89 billion, a P/E ratio of 192.15, a P/E/G ratio of 5.17 and a beta of 1.24. Axon Enterprise, Inc. has a 52-week low of $273.52 and a 52-week high of $755.05. The company has a fifty day moving average price of $620.57 and a 200-day moving average price of $610.50.

Axon Enterprise (NASDAQ:AXON - Get Free Report) last posted its earnings results on Wednesday, May 7th. The biotechnology company reported $1.41 earnings per share for the quarter, beating analysts' consensus estimates of $1.34 by $0.07. The business had revenue of $603.63 million during the quarter, compared to analyst estimates of $585.67 million. Axon Enterprise had a return on equity of 7.50% and a net margin of 15.37%. The company's quarterly revenue was up 31.3% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $1.15 EPS. As a group, analysts anticipate that Axon Enterprise, Inc. will post 5.8 earnings per share for the current year.

Insider Buying and Selling at Axon Enterprise

In other news, President Joshua Isner sold 9,000 shares of Axon Enterprise stock in a transaction dated Monday, May 12th. The stock was sold at an average price of $683.31, for a total transaction of $6,149,790.00. Following the completion of the sale, the president now owns 308,714 shares in the company, valued at approximately $210,947,363.34. This trade represents a 2.83% decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, Director Caitlin Elizabeth Kalinowski sold 1,300 shares of Axon Enterprise stock in a transaction dated Monday, May 19th. The shares were sold at an average price of $738.84, for a total value of $960,492.00. Following the sale, the director now owns 4,829 shares of the company's stock, valued at approximately $3,567,858.36. This trade represents a 21.21% decrease in their position. The disclosure for this sale can be found here. Insiders sold 34,969 shares of company stock valued at $23,127,314 in the last quarter. 5.70% of the stock is currently owned by corporate insiders.

Axon Enterprise Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.